Updated Date: Fri, 24 Apr 2020 00:00:00 EDT

Updated Date: Fri, 24 Apr 2020 00:00:00 EDT

Updated Date: Fri, 24 Apr 2020 00:00:00 EDT

Days after U.S. officials reported the first positive controlled data for Gilead’s remdesivir in COVID-19, the FDA has […]

There is never a good time for a pandemic, but covid-19 kicked doctors while we were down. Between […]

AstraZeneca saw its China sales growth slow down in the first quarter, when the coronavirus outbreak was at […]

Moderna Therapeutics has partnered with the federal government to create an mRNA-based COVID-19 vaccine it hopes to speed […]

At the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO […]

Gilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate […]

AbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products […]